These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 19596067)

  • 1. Analysis of the mechanism by which tryptophan analogs inhibit human myeloperoxidase.
    Sliskovic I; Abdulhamid I; Sharma M; Abu-Soud HM
    Free Radic Biol Med; 2009 Oct; 47(7):1005-13. PubMed ID: 19596067
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Melatonin is a potent inhibitor for myeloperoxidase.
    Galijasevic S; Abdulhamid I; Abu-Soud HM
    Biochemistry; 2008 Feb; 47(8):2668-77. PubMed ID: 18237195
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel multistep mechanism for oxygen binding to ferrous hemoproteins: rapid kinetic analysis of ferrous-dioxy myeloperoxidase (compound III) formation.
    Abu-Soud HM; Raushel FM; Hazen SL
    Biochemistry; 2004 Sep; 43(36):11589-95. PubMed ID: 15350145
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of the myeloperoxidase chlorinating activity by non-steroidal anti-inflammatory drugs: flufenamic acid and its 5-chloro-derivative directly interact with a recombinant human myeloperoxidase to inhibit the synthesis of hypochlorous acid.
    Van Antwerpen P; Dufrasne F; Lequeux M; Boudjeltia KZ; Lessgyer I; Babar S; Moreau P; Moguilevsky N; Vanhaeverbeek M; Ducobu J; Nève J
    Eur J Pharmacol; 2007 Sep; 570(1-3):235-43. PubMed ID: 17610876
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exploitation of the unusual thermodynamic properties of human myeloperoxidase in inhibitor design.
    Jantschko W; Furtmüller PG; Zederbauer M; Neugschwandtner K; Lehner I; Jakopitsch C; Arnhold J; Obinger C
    Biochem Pharmacol; 2005 Apr; 69(8):1149-57. PubMed ID: 15794935
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanism of interaction of betanin and indicaxanthin with human myeloperoxidase and hypochlorous acid.
    Allegra M; Furtmüller PG; Jantschko W; Zederbauer M; Tesoriere L; Livrea MA; Obinger C
    Biochem Biophys Res Commun; 2005 Jul; 332(3):837-44. PubMed ID: 15913556
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction between myeloperoxidase and antibodies against myeloperoxidase measured by chemiluminescence.
    Nässberger L
    J Biolumin Chemilumin; 1993; 8(1):33-7. PubMed ID: 8386428
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential role of tryptophan and chloride in the inhibition of human myeloperoxidase.
    Galijasevic S; Abdulhamid I; Abu-Soud HM
    Free Radic Biol Med; 2008 Apr; 44(8):1570-7. PubMed ID: 18279680
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carbon monoxide-releasing molecule 3 inhibits myeloperoxidase (MPO) and protects against MPO-induced vascular endothelial cell activation/dysfunction.
    Patterson EK; Fraser DD; Capretta A; Potter RF; Cepinskas G
    Free Radic Biol Med; 2014 May; 70():167-73. PubMed ID: 24583458
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tyrosine kinase inhibitors. 6. Structure-activity relationships among N- and 3-substituted 2,2'-diselenobis(1H-indoles) for inhibition of protein tyrosine kinases and comparative in vitro and in vivo studies against selected sulfur congeners.
    Showalter HD; Sercel AD; Leja BM; Wolfangel CD; Ambroso LA; Elliott WL; Fry DW; Kraker AJ; Howard CT; Lu GH; Moore CW; Nelson JM; Roberts BJ; Vincent PW; Denny WA; Thompson AM
    J Med Chem; 1997 Feb; 40(4):413-26. PubMed ID: 9046331
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of the chlorinating activity of myeloperoxidase by tempol: revisiting the kinetics and mechanisms.
    Queiroz RF; Vaz SM; Augusto O
    Biochem J; 2011 Nov; 439(3):423-31. PubMed ID: 21749327
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis of some 2(3H)-benzoxazolone derivatives and their in-vitro effects on human leukocyte myeloperoxidase activity.
    Soyer Z; Bas M; Pabuccuoglu A; Pabuccuoglu V
    Arch Pharm (Weinheim); 2005 Sep; 338(9):405-10. PubMed ID: 16143956
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myeloperoxidase: a target for new drug development?
    Malle E; Furtmüller PG; Sattler W; Obinger C
    Br J Pharmacol; 2007 Nov; 152(6):838-54. PubMed ID: 17592500
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myeloperoxidase is a key regulator of oxidative stress mediated apoptosis in myeloid leukemic cells.
    Nakazato T; Sagawa M; Yamato K; Xian M; Yamamoto T; Suematsu M; Ikeda Y; Kizaki M
    Clin Cancer Res; 2007 Sep; 13(18 Pt 1):5436-45. PubMed ID: 17875773
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resveratrol inhibits the activity of equine neutrophil myeloperoxidase by a direct interaction with the enzyme.
    Kohnen S; Franck T; Van Antwerpen P; Boudjeltia KZ; Mouithys-Mickalad A; Deby C; Moguilevsky N; Deby-Dupont G; Lamy M; Serteyn D
    J Agric Food Chem; 2007 Oct; 55(20):8080-7. PubMed ID: 17844991
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nitrite enhances neutrophil-induced DNA strand breakage in pulmonary epithelial cells by inhibition of myeloperoxidase.
    Knaapen AM; Schins RP; Borm PJ; van Schooten FJ
    Carcinogenesis; 2005 Sep; 26(9):1642-8. PubMed ID: 15878909
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conception of myeloperoxidase inhibitors derived from flufenamic acid by computational docking and structure modification.
    Van Antwerpen P; Prévost M; Zouaoui-Boudjeltia K; Babar S; Legssyer I; Moreau P; Moguilevsky N; Vanhaeverbeek M; Ducobu J; Nève J; Dufrasne F
    Bioorg Med Chem; 2008 Feb; 16(4):1702-20. PubMed ID: 18063373
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ordered cleavage of myeloperoxidase ester bonds releases active site heme leading to inactivation of myeloperoxidase by benzoic acid hydrazide analogs.
    Huang J; Smith F; Panizzi P
    Arch Biochem Biophys; 2014 Apr; 548():74-85. PubMed ID: 24632143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Indole ring oxidation by activated leukocytes prevents the production of hypochlorous acid.
    Ximenes VF; Paino IM; Faria-Oliveira OM; Fonseca LM; Brunetti IL
    Braz J Med Biol Res; 2005 Nov; 38(11):1575-83. PubMed ID: 16258625
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A three-dimensional quantitative structure-activity analysis of a new class of bisphenol topoisomerase IIalpha inhibitors.
    Liang H; Wu X; Yalowich JC; Hasinoff BB
    Mol Pharmacol; 2008 Mar; 73(3):686-96. PubMed ID: 18045852
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.